Prader-Willi is different from conditions such as Down syndrome and autism, but, like autism, it is a spectrum disorder that can result in different issues in different children, Bystrak said.

About PWS The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births in the U.S.

Treatments: There is no cure for Prader-Willi syndrome. Treatments vary depending which symptoms a person has, when those symptoms began and how severe they are.

Miller will discuss the current treatment landscape and unmet medical need for patients with Prader-Willi Syndrome (PWS), and data from Soleno's once-daily Diazoxide Choline Controlled Release ...

Beta: -1.44 Market Cap as of October 13: $2.13 Billion Soleno Therapeutics (NASDAQ:SLNO) is a biotech company that focuses on rare diseases, particularly Prader-Willi Syndrome (PWS) hyperphagia.

We recently published a list of 10 Most Promising Small-Cap Stocks According to Hedge Funds. In this article, we are going to take a look at where Soleno Therapeutics, Inc.

Prader-Willi syndrome affects approximately 8,000 to 10,000 people in the US. Currently there is no FDA-approved treatment for hyperphagia associated with the disorder, according to Acadia.

There is no cure for Prader Willi Syndrome, but with a good diet and a lot of physical therapy, life can be easier. Despite being hungry all of the time, Heather’s goal is to see that Journey ...

Soleno Therapeutics, Inc. announced its participation in the 2025 United In Hope: International Prader-Willi Syndrome Conference, scheduled for June 24-28, 2025, in Phoenix, AZ. The company will ...

The drug, to be called Vykat XR, treats hyperphagia, the hallmark symptom of the Prader-Willi syndrome, a genetic disorder caused by full or partial deletions on chromosome 15 that affect the ...

Miller JL, Gevers E, Bridges N, et al. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: A double-blind, placebo-controlled trial.

Soleno Therapeutics slides after FDA review extension of its Prader-Willi syndrome treatment Nov. 26, 2024 8:48 AM ET Soleno Therapeutics, Inc. (SLNO) Stock By: Nilanjana Basu, SA News Editor ...